GAITHERSBURG, Md., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Barclay "Buck" Phillips, SVP, Chief Financial Officer and Treasurer, will present at the Wedbush Securities Life Sciences Management Access Conference to be held on Wednesday, August 13, 2014 at 3:40 pm ET in New York City at the Le Parker Meridien hotel.
A live webcast link for the presentation will be available via the company's website at www.novavax.com under Investor Info/Events.
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. CONTACT: Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Novavax, Inc. 240-268-2000
Help employers find you! Check out all the jobs and post your resume.